Reuters
Dater: May 30, 2020
FILE PHOTO: An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS/File Photo
Governments are racing to bolster supplies of remdesivir, which U.S. regulators this month approved for emergency use. California-based Gilead has said it will donate 1.5 million doses of remdesivir, enough to treat at least 140,000 patients, to combat the global pandemic.
Taiwan’s Central Epidemic Command Centre said the Taiwan Food and Drug Administration took into account “the fact that the efficacy and safety of remdesivir has been supported by preliminary evidence” and its use is being approved by other countries.
On that basis, the centre said the conditions had been met for approval of the drug for use in patients with “severe” COVID-19 infection. [FULL STORY]
